Logo

Netherlands Cancer Institute

Single Metastatic Cancer Genome Analysis Appears Sufficient to ID Biomarkers, Treatment Options

For many metastatic cancer patients, actionable genomic alterations uncovered in the initial analysis did not change much in later biopsies.

With Support From Lawmakers, WGS Becoming More Accessible to Netherlands' Cancer Patients
Premium

Based on results from a pilot study, Dutch lawmakers are advancing a proposal to make WGS a standard test for advanced cancer patients.

Breast Cancer Polygenic Risk Score Can Help Predict Risk of Contralateral Disease

Based on the study results, the score could be combined with other risk factors to improve predictions of contralateral breast cancer and stratify patients.

Metastatic Cancer Treatment Markers Identified in Clinical WGS Study

Interim results from a study in the Netherlands suggest whole-genome sequencing can be done fast enough to uncover treatment targets in metastatic cancer patients.

Prostate Cancer Metastasis Linked to Development-Related Epigenetic Shift

Transcription factor reprogramming during prostate cancer metastases appears to involve epigenetic changes that resemble those at play during prostate development, new research finds.

Sep 30, 2019

Netherlands Drug Repurposing, Tumor Profiling Trial Results Reported at ESMO

Jul 24, 2019

Dutch Startup Gen-X Offers Functional Genome Annotation Services
Premium

Jan 15, 2018

Desktop Genetics Licenses Genome Editing Assessment Tech

Feb 10, 2017

Cancer​ ​Research​ ​UK​ ​Unveils​ ​First​ ​Winners​ ​of​ ​Grand​ ​Challenge​ ​Competition

Jul 14, 2016

Immune Gene Mutations Found in Immunotherapy-Resistant Metastatic Melanoma Patients

May 10, 2016

'Immunogram' Could Better Personalize Cancer Immunotherapy, Researchers Say
Premium

Aug 3, 2012

Dutch Researchers Head SU2C Tumor Profiling Study

Mar 9, 2012

Netherlands Provides $18M for New Proteomics Facility

Oct 31, 2011

EU Funds Breast Cancer Profiling Consortium

Jun 15, 2011

Agendia to Collaborate with MD Anderson, Netherlands Institute to Further Validate ColoPrint
Premium

Jun 9, 2011

Agendia, MD Anderson, Netherlands Cancer Institute Partner on Colorectal Cancer Research

May 10, 2011

Agendia, AstraZeneca, NKI Partner to ID Colorectal Cancer Subtypes

Breaking News
The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.